A. Eldridge George's Insider Trades & SAST Disclosures
A. Eldridge George's most recent trade in Aerovate Therapeutics Inc was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Eldridge George.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 28,763 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 14 Jun 2024 | 15,000 | 20,022 | - | 2.1 | 32,100 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 14 Jun 2024 | 15,000 | 5,022 | - | 25.0 | 375,450 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 10 Apr 2024 | 7,500 | 9,460 | - | 2.1 | 16,050 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 7,500 | 43,763 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 26.77 per share. | 10 Apr 2024 | 6,729 | 2,731 | - | 26.8 | 180,139 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 27.56 per share. | 10 Apr 2024 | 771 | 1,960 | - | 27.6 | 21,252 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 01 Apr 2024 | 12,495 | 1,960 | - | 31.2 | 390,208 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 01 Apr 2024 | 12,495 | 14,455 | - | 2.1 | 26,739 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 12,495 | 15,768 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 12 Mar 2024 | 2,051 | 4,011 | - | 2.1 | 4,389 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 12 Mar 2024 | 2,051 | 1,960 | - | 25.0 | 51,370 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 2,051 | 53,279 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 2,016 | 51,263 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 12 Mar 2024 | 2,016 | 3,976 | - | 2.1 | 4,314 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 12 Mar 2024 | 2,016 | 1,960 | - | 25.0 | 50,445 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Mar 2024 | 22,386 | 24,346 | - | 2.1 | 47,906 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Mar 2024 | 22,386 | 1,960 | - | 25.0 | 559,688 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 20,986 | 58,877 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 3,433 | 55,330 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Mar 2024 | 3,433 | 5,393 | - | 2.1 | 7,347 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.24 per share. | 07 Mar 2024 | 3,423 | 1,970 | - | 25.2 | 86,404 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,400 | 28,263 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 114 | 58,763 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Mar 2024 | 114 | 1,960 | - | 25 | 2,850 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Mar 2024 | 114 | 2,074 | - | 2.1 | 244 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 07 Mar 2024 | 10 | 1,960 | - | 26.3 | 263 | Common Stock |
| Aerovate Therapeutics Inc | A. Eldridge George | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 66,586 | 66,586 | - | - | Stock Options (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 09 Dec 2022 | 10,000 | 1,960 | - | 30.0 | 300,428 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 09 Dec 2022 | 10,000 | 11,960 | - | 2.1 | 21,400 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 7,094 | 29,663 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 09 Dec 2022 | 3,969 | 5,929 | - | 2.1 | 8,494 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 3,969 | 36,757 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 24.23 per share. | 09 Dec 2022 | 3,386 | 2,543 | - | 24.2 | 82,055 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 2,906 | 79,863 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.23 per share. | 09 Dec 2022 | 583 | 1,960 | - | 25.2 | 14,711 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Dec 2022 | 12,011 | 13,971 | - | 2.1 | 25,704 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 11,637 | 84,656 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Dec 2022 | 11,637 | 13,597 | - | 2.1 | 24,903 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 24.20 per share. | 07 Dec 2022 | 11,031 | 1,960 | - | 24.2 | 266,974 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 10,124 | 40,726 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.37 per share. | 07 Dec 2022 | 7,079 | 6,518 | - | 19.4 | 137,090 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 20.40 per share. | 07 Dec 2022 | 4,558 | 1,960 | - | 20.4 | 92,993 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,887 | 82,769 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 07 Dec 2022 | 960 | 13,011 | - | 20.1 | 19,314 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 20.60 per share. | 07 Dec 2022 | 20 | 12,991 | - | 20.6 | 412 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.06 per share. | 30 Nov 2022 | 85 | 1,960 | - | 19.1 | 1,620 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 30 Nov 2022 | 85 | 2,045 | - | 2.1 | 182 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 85 | 96,293 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 1,261 | 96,378 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.07 per share. | 23 Nov 2022 | 1,261 | 1,960 | - | 19.1 | 24,048 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 23 Nov 2022 | 1,261 | 3,221 | - | 2.1 | 2,699 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 18 Nov 2022 | 861 | 2,821 | - | 2.1 | 1,843 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 861 | 97,815 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.45 per share. | 18 Nov 2022 | 780 | 2,041 | - | 19.5 | 15,174 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 174 | 97,639 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 18 Nov 2022 | 174 | 1,960 | - | 19.0 | 3,308 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 18 Nov 2022 | 174 | 2,134 | - | 2.1 | 372 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 18 Nov 2022 | 81 | 1,960 | - | 20.1 | 1,631 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 2 | 97,813 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 18 Nov 2022 | 2 | 1,960 | - | 19 | 38 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 18 Nov 2022 | 2 | 1,962 | - | 2 | 4 | Common Stock |
| Aerovate Therapeutics Inc | George A. Eldridge | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 65,433 | 65,433 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 98,676 | 98,676 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 76,900 | 76,900 | - | - | Stock Option (Right to Buy) | |
| Aerovate Therapeutics Inc | George A. Eldridge | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 50,850 | 50,850 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges